These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7543375)

  • 21. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2.
    Schwartz JD; Monea S; Marcus SG; Patel S; Eng K; Galloway AC; Mignatti P; Shamamian P
    J Surg Res; 1998 Apr; 76(1):79-85. PubMed ID: 9695744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collagenase-2 and -3 are inhibited by doxycycline in the chronically inflamed lung in bronchiectasis.
    Sepper R; Prikk K; Tervahartiala T; Konttinen YT; Maisi P; Lópes-Otín C; Sorsa T
    Ann N Y Acad Sci; 1999 Jun; 878():683-5. PubMed ID: 10415807
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat.
    Mucha SA; Meleń-Mucha G; Godlewski A; Stepień H
    Virchows Arch; 2007 Mar; 450(3):335-41. PubMed ID: 17235567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
    Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
    Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease.
    Boyle JR; McDermott E; Crowther M; Wills AD; Bell PR; Thompson MM
    J Vasc Surg; 1998 Feb; 27(2):354-61. PubMed ID: 9510291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetracycline and doxycycline inhibit pleural fluid metalloproteinases. A possible mechanism for chemical pleurodesis.
    Hurewitz AN; Wu CL; Mancuso P; Zucker S
    Chest; 1993 Apr; 103(4):1113-7. PubMed ID: 8131449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doxycycline reduces the expression and activity of matrix metalloproteinase-2 in the periodontal ligament of the rat incisor without altering the eruption process.
    Gomes JR; Omar NF; Neves JDS; Novaes PD
    J Periodontal Res; 2017 Jun; 52(3):353-359. PubMed ID: 27417412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.
    Taraboletti G; Garofalo A; Belotti D; Drudis T; Borsotti P; Scanziani E; Brown PD; Giavazzi R
    J Natl Cancer Inst; 1995 Feb; 87(4):293-8. PubMed ID: 7535861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective endothelial growth inhibition by tetracyclines that inhibit collagenase.
    Guerin C; Laterra J; Masnyk T; Golub LM; Brem H
    Biochem Biophys Res Commun; 1992 Oct; 188(2):740-5. PubMed ID: 1445318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxycycline protects serum alpha-1-antitrypsin from human neutrophil collagenase.
    Sorsa T; Konttinen YT; Lindy O; Suomalainen K; Ingman T; Saari H; Halinen S; Lee HM; Golub LM; Hall J
    Agents Actions Suppl; 1993; 39():225-9. PubMed ID: 8456633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article.
    Ingman T; Sorsa T; Suomalainen K; Halinen S; Lindy O; Lauhio A; Saari H; Konttinen YT; Golub LM
    J Periodontol; 1993 Feb; 64(2):82-8. PubMed ID: 8433257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of chemically modified tetracyclines (CMTs) on human keratinocyte proliferation and migration.
    Mäkelä M; Sorsa T; Uitto VJ; Salo T; Teronen O; Larjava H
    Adv Dent Res; 1998 Nov; 12(2):131-5. PubMed ID: 9972137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation.
    Lee CZ; Yao JS; Huang Y; Zhai W; Liu W; Guglielmo BJ; Lin E; Yang GY; Young WL
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1157-64. PubMed ID: 16395286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
    Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
    Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
    Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
    J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity.
    Ryan ME; Usman A; Ramamurthy NS; Golub LM; Greenwald RA
    Curr Med Chem; 2001 Feb; 8(3):305-16. PubMed ID: 11172685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.
    Low JA; Johnson MD; Bone EA; Dickson RB
    Clin Cancer Res; 1996 Jul; 2(7):1207-14. PubMed ID: 9816289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis.
    Porter KE; Thompson MM; Loftus IM; McDermott E; Jones L; Crowther M; Bell PR; London NJ
    Eur J Vasc Endovasc Surg; 1999 May; 17(5):404-12. PubMed ID: 10329524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.
    Lee HM; Ciancio SG; Tüter G; Ryan ME; Komaroff E; Golub LM
    J Periodontol; 2004 Mar; 75(3):453-63. PubMed ID: 15088884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor batimastat against B16F10 melanoma in mice.
    Dabrowska A; Giermasz A; Marczak M; Gołab J; Jakóbisiak M
    Anticancer Res; 2000; 20(1A):391-4. PubMed ID: 10769685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.